Linical Co (TSE:2183) Other Long-Term Liabilities: 円29 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:2183 Linical Co Ltd TSE:2183
40 GF Score
Price 円203.00
GF Value 円340.50
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Linical Co Other Long-Term Liabilities?

Linical Co TSE:2183 -0.49% 40 Other Long-Term Liabilities is 円29 Mil as of Mar. 2026. GuruFocus rates TSE:2183 with a GF Score™ of 40/100 and a GF Value™ of 円340.50 (Possible Value Trap). The stock has 5 warning signs investors should review.

Linical Co's other long-term liabilities for the quarter that ended in Mar. 2026 was 円29 Mil.

Linical Co's quarterly other long-term liabilities increased from Mar. 2025 (円23 Mil) to Sep. 2025 (円24 Mil) and increased from Sep. 2025 (円24 Mil) to Mar. 2026 (円29 Mil).

Linical Co's annual other long-term liabilities declined from Mar. 2024 (円27 Mil) to Mar. 2025 (円23 Mil) but then increased from Mar. 2025 (円23 Mil) to Mar. 2026 (円29 Mil).

Linical Co Other Long-Term Liabilities Related Terms

Linical Co Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Linical Co's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Linical Co Other Long-Term Liabilities Chart

Linical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41.03 27.31 26.67 23.43 29.45

Linical Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.67 24.56 23.43 23.57 29.45
TSE:2183
40GF Score
Linical Co Ltd TSE:2183
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Linical Co Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of 円29 Mil mean?
Linical Co (TSE:2183) has a Other Long-Term Liabilities of 円29 Mil as of Mar. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Linical Co and its competitors.
Is Linical Co's Other Long-Term Liabilities too high?
Linical Co's current Other Long-Term Liabilities is 円29 Mil. Overall, Linical Co has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's Other Long-Term Liabilities compare to VRTX and REGN?
Linical Co's Other Long-Term Liabilities of 円29 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Biotechnology company?
A good Other Long-Term Liabilities depends on the Biotechnology industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Linical Co and its competitors. Linical Co's current Other Long-Term Liabilities is 円29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円340.50, compared to a current price of 円203.00 — trading 40.4% below its estimated fair value. The current Other Long-Term Liabilities is 円29 Mil. Linical Co's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Other Long-Term Liabilities is 円29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Linical Co (TSE:2183) Overvalued in 2026?

Based on GuruFocus' analysis, Linical Co stock appears to be undervalued. The current stock price of 円203.00 is trading 40.4% below its estimated GF Value™ of 円340.50. GuruFocus considers Linical Co to be Possible Value Trap.

Key valuation signals for TSE:2183:

  • Other Long-Term Liabilities: 円29 Mil
  • GF Value™: 円340.50 vs. price of 円203.00 (40.4% below fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Linical Co Business Description

Address 1-6-1 Miyahara, 10th floor, Shin-Osaka Brick Building, Yodogawa-ku, Osaka, JPN, 532-0003
Linical Co Ltd is a pharmaceutical company.
40GF Score

Get the complete analysis for TSE:2183

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円203.00
Price
円340.50
GF Value